Nuvation Bio Inc (NUVB) Stock Price, Quote & News

Company Profile

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology. Its lead product candidate is taletrectinib, an ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. The company is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 2 clinical trials; NUV-1511, a drug-drug conjugate for use in chemotherapy agent that suppresses the growth of various advanced solid tumors; a...

Industry: Biotechnology

Sector: Healthcare

Phone: 332 208 6102

Website: www.nuvationbio.com

Address:

1500 Broadway, Suite 1401, New York, United States

IVAlert Sep. 16 at 9:09 PM

$NUVB 30-Day Options IV is 81.2%% 60-Day Options IV is 75.6%% Options are currently 5.6% more expensive than the historical IV (60-day). It's a good time to be selling premiums as the options premiums are overvalued $NUVB Options Trading Guidance: Sell options premium https://ivalerts.com/trades

0 · Reply

MoneyGroupLLC Sep. 16 at 8:02 PM

Enter: $NUVB OCT 17 2025 $5 CALLS Buy in Price: $0.05 - $0.05 Take Profit: $0.07 Stop Bleeding: $0.04 ROI Potential: 41% Exit Within: 40 Minutes https://moneygroup.us/alerts

0 · Reply

prover Sep. 16 at 7:48 PM

$NUVB oh no

1 · Reply

ConsulHorkos Sep. 16 at 7:45 PM

$NUVB nice rise on low volume.

2 · Reply

kriscory69 Sep. 16 at 7:37 PM

$NUVB beautiful

0 · Reply

MoneyGroupLLC Sep. 16 at 7:10 PM

Enter: $NUVB OCT 17 2025 $5 CALLS Buy in Price: $0.05 - $0.05 Take Profit: $0.07 Stop Bleeding: $0.04 ROI Potential: 34% Exit Within: 44 Minutes https://moneygroup.us/alerts

0 · Reply